Ameriprise
ARVN icon

Ameriprise’s Arvinas ARVN Stock Holding History

Ameriprise’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Sell
185,347
-148
-0.1% -$1.38K ﹤0.01% 3211
2026
Q1 		$1.97M Buy
185,495
+147,624
+390% +$1.83M ﹤0.01% 2973
2025
Q4 		$449K Buy
37,871
+110
+0.3% +$1.2K ﹤0.01% 3664
2025
Q3 		$322K Sell
37,761
-745
-2% -$5.65K ﹤0.01% 3777
2025
Q2 		$283K Buy
+38,506
New +$284K ﹤0.01% 3713
2025
Q1 		– Sell
-116,513
Closed -$2.23M – 4022
2024
Q4 		$2.23M Buy
116,513
+19,505
+20% +$474K ﹤0.01% 2870
2024
Q3 		$2.39M Buy
97,008
+2,350
+2% +$61.4K ﹤0.01% 2828
2024
Q2 		$2.52M Buy
94,658
+20,265
+27% +$646K ﹤0.01% 2757
2024
Q1 		$3.07M Buy
74,393
+418
+0.6% +$18.3K ﹤0.01% 2654
2023
Q4 		$3.04M Buy
73,975
+15,190
+26% +$355K ﹤0.01% 2658
2023
Q3 		$1.15M Buy
58,785
+4,660
+9% +$114K ﹤0.01% 3074
2023
Q2 		$1.34M Sell
54,125
-14,006
-21% -$360K ﹤0.01% 3048
2023
Q1 		$1.86M Buy
68,131
+21,252
+45% +$671K ﹤0.01% 2882
2022
Q4 		$1.6M Sell
46,879
-4,155
-8% -$175K ﹤0.01% 2907
2022
Q3 		$2.27M Buy
51,034
+5,367
+12% +$261K ﹤0.01% 2729
2022
Q2 		$1.92M Buy
45,667
+5,757
+14% +$289K ﹤0.01% 2825
2022
Q1 		$2.69M Buy
39,910
+4,538
+13% +$309K ﹤0.01% 2784
2021
Q4 		$2.9M Sell
35,372
-5,511
-13% -$448K ﹤0.01% 2803
2021
Q3 		$3.36M Buy
40,883
+3,351
+9% +$296K ﹤0.01% 2635
2021
Q2 		$2.89M Buy
37,532
+3,188
+9% +$221K ﹤0.01% 2758
2021
Q1 		$2.27M Sell
34,344
-7,935
-19% -$607K ﹤0.01% 2806
2020
Q4 		$3.59M Buy
42,279
+1,722
+4% +$59.4K ﹤0.01% 2479
2020
Q3 		$957K Buy
40,557
+19,962
+97% +$579K ﹤0.01% 2991
2020
Q2 		$691K Buy
+20,595
New +$874K ﹤0.01% 3071

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise's ARVN Position: Q2 2026 in Review

Ameriprise reduced its Arvinas (ARVN) stake by 0.08% in Q2 2026, selling an estimated $1.38K and leaving 185,347 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #3211.

Ameriprise first reported a position in ARVN in Q2 2020 and has held it in 24 quarters since. The position peaked at $3.59M in Q4 2020. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • Ameriprise held 185,347 shares of Arvinas worth $1.54M as of Q2 2026.
  • Ameriprise sold 148 Arvinas shares in Q2 2026, an estimated $1.38K.
  • Arvinas made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3211 holding.
  • Ameriprise first reported a position in Arvinas in Q2 2020 and has held it in 24 quarters since.
  • Ameriprise's Arvinas position peaked at $3.59M in Q4 2020.
  • 200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.